Article
Nucleoside and nucleotide inhibitors of HIV-1 replication.
Cellular and molecular life sciences : CMLS - 1 Jan 2006
Vivet-Boudou V, Didierjean J, Isel C, Marquet R
Abstract excerpt
HIV-1 reverse transcriptase (RT) is one of the main targets for antiviral therapy. Two classes of RT inhibitors can be distinguished: those that are nucleoside or nucleotide analogues (sharing the common NRTIs abbreviation) and those that are not. This review focuses on the NRTIs, which are highly efficient in slowing down viral replication and are used in combination regimens. Unfortunately, the current...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
